Jinhe Biotechnology (002688.SZ) stated on the investor platform on August 21 that the company invested in Yunnan Rueitai Biological Products Co., Ltd., a subsidiary of Jinhe Youben. The company has CE-certified testing reagents for monkey-pox virus using nucleic acid POCT fluorescence method. The company currently does not have drugs to treat monkeypox virus.
金河生物(002688.SZ)：目前没有治疗猴痘病毒的药物
Jinhe Biotechnology (002688.SZ): Currently, there is no medication for treating monkeypox virus.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated